Ya-Ling Hsu Selected Research

Leptin

7/2022	Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis.
5/2022	Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Ling Hsu Research Topics

Disease

72	Neoplasms (Cancer) 04/2024 - 11/2004
29	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2004
27	Breast Neoplasms (Breast Cancer) 06/2023 - 04/2005
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018 - 07/2004
16	Neoplasm Metastasis (Metastasis) 05/2022 - 04/2010
15	Asthma (Bronchial Asthma) 01/2023 - 04/2011
9	Inflammation (Inflammations) 01/2023 - 04/2005
8	Adenocarcinoma of Lung 01/2024 - 08/2015
7	Adenocarcinoma 01/2014 - 03/2005
6	Carcinogenesis 12/2021 - 03/2004
6	Liver Neoplasms (Liver Cancer) 12/2010 - 03/2004
5	Airway Remodeling 11/2015 - 04/2011
4	Hypoxia (Hypoxemia) 04/2021 - 09/2017
4	Urinary Bladder Neoplasms (Bladder Cancer) 12/2011 - 10/2007
4	Hepatocellular Carcinoma (Hepatoma) 05/2009 - 09/2004
3	Hypersensitivity (Allergy) 01/2023 - 04/2010
3	Chronic Renal Insufficiency 01/2021 - 01/2017
3	Bone Resorption 05/2015 - 06/2013
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 03/2011
2	Infections 04/2024 - 01/2016
2	Leukemia 04/2024 - 05/2012
2	Hyperglycemia 10/2022 - 05/2022
2	Nasopharyngeal Carcinoma 07/2022 - 05/2022
2	Melanoma (Melanoma, Malignant) 10/2021 - 01/2008
2	Carcinoma (Carcinomatosis) 01/2021 - 07/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 06/2017
2	Cognitive Dysfunction 01/2020 - 02/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 11/2015
2	Colonic Neoplasms (Colon Cancer) 08/2018 - 01/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2018 - 12/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 07/2017
2	Water Intoxication 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

16	MicroRNAs (MicroRNA)IBA 01/2023 - 06/2013
12	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2005
12	FlavonoidsIBA 03/2016 - 03/2004
9	CytokinesIBA 01/2023 - 05/2009
9	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 10/2004
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2017
7	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 08/2007
7	Fas Ligand Protein (Fas Ligand)IBA 07/2010 - 09/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 07/2007
6	Small Interfering RNA (siRNA)IBA 09/2020 - 04/2005
6	Conditioned Culture MediaIBA 02/2016 - 08/2011
6	NF-kappa B (NF-kB)IBA 12/2012 - 09/2004
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
5	LigandsIBA 01/2023 - 11/2008
5	Interleukin-8 (Interleukin 8)IBA 12/2014 - 04/2010
4	LipidsIBA 06/2023 - 06/2017
4	phthalic acid (phthalate)IBA 01/2023 - 04/2011
4	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 12/2021 - 04/2016
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2007
4	Phosphotransferases (Kinase)IBA 02/2020 - 06/2008
4	ChemokinesIBA 02/2018 - 04/2010
4	Estrogen ReceptorsIBA 02/2018 - 02/2014
4	Galectin 1 (LGALS1)IBA 05/2016 - 02/2011
3	Interleukin-33IBA 01/2023 - 12/2017
3	Uremic ToxinsIBA 01/2021 - 02/2019
3	Cadherins (E-Cadherin)IBA 02/2018 - 01/2012
3	Cysteine (L-Cysteine)FDA Link 01/2018 - 07/2017
3	EnzymesIBA 09/2017 - 12/2006
3	3- hydroxy- 4- methoxy- beta- methyl- beta- nitrostyreneIBA 06/2017 - 01/2017
3	Interleukin-10 (Interleukin 10)IBA 12/2016 - 02/2011
3	Benzo(a)pyreneIBA 03/2016 - 07/2011
3	EstersIBA 02/2016 - 04/2011
3	4-boronic acid benzophenoneIBA 02/2016 - 04/2011
3	tricetinIBA 05/2015 - 09/2009
3	Parathyroid Hormone-Related ProteinIBA 05/2015 - 06/2013
3	shogaolIBA 02/2015 - 10/2009
3	LactonesIBA 06/2010 - 05/2009
3	SesquiterpenesIBA 06/2010 - 05/2009
3	dehydrocostus lactoneIBA 06/2010 - 05/2009
3	isoliquiritigenin (GU 17)IBA 07/2009 - 07/2004
3	kotomolide AIBA 07/2008 - 11/2007
3	plumbaginIBA 01/2008 - 08/2006
3	ellipticineIBA 04/2006 - 06/2005
2	InterleukinsIBA 01/2023 - 08/2014
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 11/2015
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2021
2	Diethylhexyl Phthalate (DEHP)IBA 01/2023 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2022
2	Advanced Glycation End ProductsIBA 10/2022 - 05/2022
2	LeptinIBA 07/2022 - 05/2022
2	Oxidoreductases (Dehydrogenase)IBA 09/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 09/2021 - 01/2021
2	Cell Adhesion MoleculesIBA 06/2021 - 05/2019
2	Tryptophan (L-Tryptophan)FDA Link 09/2020 - 05/2016
2	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 02/2011
2	Cyclin AIBA 02/2020 - 06/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 09/2017
2	Nonesterified Fatty Acids (NEFA)IBA 11/2018 - 09/2017
2	AllergensIBA 02/2018 - 05/2015
2	Angiopoietin-2IBA 01/2018 - 01/2017
2	Phytoestrogens (Phytoestrogen)IBA 01/2018 - 02/2014

Therapy/Procedure

7	Therapeutics 04/2024 - 05/2011
6	Immunotherapy 05/2022 - 02/2011
4	Drug Therapy (Chemotherapy) 12/2015 - 06/2008
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2008 - 07/2004
2	Renal Dialysis (Hemodialysis) 01/2020 - 01/2018